Table 2.
Outcomes | Study Participants | P-value | ||
---|---|---|---|---|
All | Swedish Descent a | Middle Eastern Descent b | ||
Total, n (%) | 510 (100) | 278 (100) | 232 (100) | - |
Fasting plasma glucose level, mean (SD), mmol/L | 5.7 (0.8) | 5.7 (0.5) | 5.6 (0.5) | 0.03d |
Abnormal (> 6.0 mmol/L) fasting plasma glucose, n (%) | 196 (38.4) | 101 (36.3) | 95 (40.9) | 0.29c |
s-25(OH)D level, median (IQR), nmol/L | 46 (28–68) | 62 (50–86) | 34 (21–47) | < 0.001e |
Inadequate (≤ 50 nmol/L) s-25(OH)D, n (%) |
213 (41.8) | 57 (20.5) | 156 (67.2) | < 0.001c |
Deficiency (< 30 nmol/L) s-25(OH)D, n (%) |
100 (19.6) | 14 (5.0) | 86 (37.1) | < 0.0001c |
a Born in Sweden to parents born in Sweden
b Born in or one parent born in Turkey, Iran, or Iraq [including region of Kurdistan]
c Based on the chi-square test
d Based on t-test
e Based on Wilcoxon rank sum test
Abbreviations: SD, standard deviation; s-25(OH)D, serum 25-hydroxy vitamin D; IQR, interquartile range